Quipt Home Medical Corp.

As of December 31, 2025, Quipt Home Medical Corp. has 44.03M shares outstanding.

These figures are as of December 31, 2025. The price-to-sales ratio is 0.79, and the price-to-book ratio stands at -1.15.

As of December 31, 2025, Quipt Home Medical Corp. trades at an EV/EBITDA multiple of 6.21 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.23 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 2,503.34 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Quipt Home Medical Corp. trades at an EV/FCF ratio of 5.94, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of December 31, 2025, Quipt Home Medical Corp. maintains a current ratio of 1.04, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 101.76, indicating elevated leverage, while an interest coverage ratio of 7.74 demonstrates adequate ability to service its debt obligations.

These figures cover the twelve months ended December 31, 2025. Return on assets (ROA) is negative at -4.08, reflecting losses generated across the asset base. Inventory turnover of 3.12 indicates how many times Quipt Home Medical Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended December 31, 2025, Quipt Home Medical Corp. posted a gross margin of 72.38, reflecting its pricing power and cost economics. The operating margin of -0.43 and net profit margin of -4.03 provide insight into operational efficiency.

These figures cover the twelve months ended December 31, 2025. Free cash flow yield stands at 22.84, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 5.54, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Quipt Home Medical Corp. shareholders.

Quipt Home Medical Corp.'s most recent stock split took place on May 13, 2021 with a 4:1 split ratio.

As of December 31, 2025, Quipt Home Medical Corp. has an Altman Z-Score of 0.82, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.